A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine
NCT01837849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104
Last updated 2013-04-23
Summary
To compare the therapeutic efficacy of recombinant human brain natriuretic peptide (rhBNP) with dobutamine on acute decompensated heart failure patients with different blood BNP levels
Conditions
- Acute Decompensated Heart Failure
Sponsors & Collaborators
-
Nantong University
lead OTHER
Principal Investigators
-
Jianhua Zhu, MD · Affiliated Hospital of Nantong University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
More Related Trials
-
Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
NCT01439789 ·Status: TERMINATED ·Phase: PHASE3
-
STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure
NCT00484770 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
NCT04107220 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
NCT00391846 ·Status: COMPLETED ·Phase: PHASE4
-
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
NCT00186329 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
NCT01808872 ·Status: COMPLETED
-
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide (Chemiluminescence Method)
NCT06691477 ·Status: COMPLETED
-
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
NCT00288730 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure
NCT06158711 ·Status: NOT_YET_RECRUITING
-
A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure
NCT00270400 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients
NCT01377987 ·Status: COMPLETED ·Phase: NA
-
NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical Study
NCT04125966 ·Status: UNKNOWN
-
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
NCT03189901 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
NCT00709865 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
NCT00475852 ·Status: COMPLETED ·Phase: PHASE3
-
CD-NP in Subjects With Stable Chronic Heart Failure
NCT00620308 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels
NCT00271557 ·Status: COMPLETED ·Phase: PHASE3
-
Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)
NCT01546532 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure
NCT06137430 ·Status: NOT_YET_RECRUITING
-
Biomarkers in Acute Heart Failure
NCT00537628 ·Status: COMPLETED
-
Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction
NCT05778084 ·Status: UNKNOWN ·Phase: PHASE4
-
Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure
NCT01543854 ·Status: COMPLETED ·Phase: PHASE2
-
Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease
NCT05439369 ·Status: UNKNOWN
-
A Study of CK-1827452 Infusion in Stable Heart Failure
NCT00624442 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
NCT03016325 ·Status: COMPLETED ·Phase: PHASE2